RxDoctor Payments Data

Jacqueline McDaniel

Psychiatric/Mental Health · Washington, PANPI 1174783062

Payments from drug & device makers

$2,877in general payments, 2019–2025

Across 173 payments — averaging $16.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Vanda Pharmaceuticals Inc.$824
  • Teva Pharmaceuticals USA, Inc.$249
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$247
  • Alkermes, Inc.$150
  • Neurocrine Biosciences, Inc.$145
  • plus $232 from 7 others

What the payments were for

  • Food & beverage$2,77496%
  • Education$1024%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,877 in reported general payments places this provider in the 85th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

See all psychiatric/mental health providers in Pennsylvania

Medicare billing

Part B allowed, 2024
$11,473
Medicare patients
48
Services billed
127

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
AustedoDeutetrabenazine11$159,403
RexultiBrexpiprazole23$33,274
Invega SustennaPaliperidone Palmitate11$33,048
Lurasidone Hcl20$6,016
Aripiprazole50$3,924
Duloxetine Hcl76$3,113
Divalproex Sodium ErDivalproex Sodium46$2,951
Trazodone Hcl101$1,483
Buspirone Hcl91$1,327
Bupropion XlBupropion Hcl64$1,287
Lamotrigine100$1,242
Quetiapine Fumarate52$1,157
Olanzapine30$1,014
Venlafaxine Hcl ErVenlafaxine Hcl63$947
Hydroxyzine Hcl40$883

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Teva Pharmaceuticals USA, Inc.Austedo$249$159,40311 claims
Otsuka America Pharmaceutical, Inc.Rexulti$98$33,27423 claims
Johnson & JohnsonInvega Sustenna$32$33,04811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 1,041 psychiatric/mental health providers in Pennsylvania.

Other psychiatric/mental health in Washington

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →